Literature DB >> 6451213

Temporal bone histopathologic findings in Down's syndrome.

T Harada, I Sando.   

Abstract

We report the results of a histopathologic study of 12 temporal bones from seven patients with Down's syndrome and of a dimensional study of the cochlea and the vestibular apparatuses of most of these specimens. Histopathologic study disclosed numerous abnormalities of the middle ear but only a limited number of inner ear abnormalities. The dimensional study showed that, while in the majority of cases the cochlea was shortened, most of the vestibular measurements were within the normal range. We also discuss hearing loss in patients with Down's syndrome and present our hypothesis that remnants of mesenchymal tissue in the round window niche might cause a certain degree of conductive hearing loss in such cases.

Entities:  

Mesh:

Year:  1981        PMID: 6451213     DOI: 10.1001/archotol.1981.00790380026007

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  5 in total

1.  Temporal bone findings in trisomy 18 and 21 syndromes.

Authors:  V Chrobok; E Simáková
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

2.  Inner ear anomalies seen on CT images in people with Down syndrome.

Authors:  Jarunee Intrapiromkul; Nafi Aygun; David E Tunkel; Marco Carone; David M Yousem
Journal:  Pediatr Radiol       Date:  2012-08-31

3.  Mastoid abnormalities in Down syndrome.

Authors:  R B Glass; D K Yousefzadeh; N J Roizen
Journal:  Pediatr Radiol       Date:  1989

4.  Hearing impairment in murine model of Down syndrome.

Authors:  Guang-Di Chen; Li Li; Andrew McCall; Dalian Ding; Zhuo Xing; Y Eugene Yu; Richard Salvi
Journal:  Front Genet       Date:  2022-08-04       Impact factor: 4.772

5.  Mechanistic Analysis of Age-Related Clinical Manifestations in Down Syndrome.

Authors:  Xu-Qiao Chen; Zhuo Xing; Quang-Di Chen; Richard J Salvi; Xuming Zhang; Benjamin Tycko; William C Mobley; Y Eugene Yu
Journal:  Front Aging Neurosci       Date:  2021-07-01       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.